Solid beverage containing human body aging BAZ2B gene inhibitor and preparation method of solid beverage
The invention relates to a solid beverage containing a human body aging BAZ2B gene inhibitor and a preparation method of the solid beverage. The yeast fermented solid beverage containing the BAZ2B gene inhibitor comprises the following components in parts by weight of 150-200 parts of calcium citrat...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a solid beverage containing a human body aging BAZ2B gene inhibitor and a preparation method of the solid beverage. The yeast fermented solid beverage containing the BAZ2B gene inhibitor comprises the following components in parts by weight of 150-200 parts of calcium citrate; 100 to 150 parts of L-magnesium malate; 4 to 20 parts of bovine colostrum; 15 to 25 parts of L-serine; 40-60 parts of Chinese velvet bean powder; 10 to 50 parts of trehalose; 2 to 6 parts of L-dopa, 0.01 to 0.05 part of a BAZ2B gene inhibitor; 20 to 30 parts of yeast extract, 0.5 to 1.5 parts of vitamin C; 0.01 to 0.02 part of edible essence; and 0.01 to 0.05 part of stevioside. According to the solid beverage, the BAZ2B gene inhibitor and the yeast extract are added, so that the solid beverage not only can provide sufficient nutrient substances for newborn cells, but also can play a role in delaying senescence by inhibiting the expression of the BAZ2B gene.
本申请涉及一种含有人体衰老BAZ2B基因抑制剂的固体饮料及其制备方法。含有BAZ2B基因抑制剂的酵母发酵固体 |
---|